RSS Feed

BEES 2.0

The discovery of PDE5 inhibitors, the drug class that includes medicines like Sildenafil (found in products such as Malegra Oral Jelly), was the result of work by scientists at the pharmaceutical company Pfizer during the late 1980s and early 1990s.

A key figure in this discovery was Dr. Simon Campbell, a medicinal chemist who led early cardiovascular research at Pfizer. His team was initially developing drugs for heart-related conditions such as angina and hypertension by targeting the enzyme phosphodiesterase type 5 (PDE5), which regulates blood vessel relaxation.

Another important contributor was Dr. David Brown, who helped guide the clinical development program. During early human trials, researchers noticed that sildenafil had a strong effect on penile blood flow, even though it was originally intended for heart disease.

Clinical studies then confirmed its effectiveness in treating Erectile Dysfunction, leading to the world’s first oral ED treatment, Viagra, which was approved in 1998.

This discovery revolutionized sexual medicine and led to the development of many generic and branded versions, including oral jelly formulations like Malegra Oral Jelly.

In summary, PDE5 inhibitors were discovered by Pfizer scientists—especially Simon Campbell’s research team—through cardiovascular drug research that unexpectedly led to a breakthrough in erectile dysfunction treatment.




https://www.genericday.com/malegra-oral-jelly.html